Related Experiment Video
Updated: Jun 5, 2026

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
Published on: March 5, 2018
Endoplasmic reticulum stress associated with caspases-4 and -2 mediates korbazol-induced B-chronic lymphocytic
S Popovic1, D Baskic, P Djurdjevic
1Department of Microbiology and Immunology, Faculty of Medicine, University of Kragujevac, Kragujevac, Serbia. suza_popovic@yahoo.com
Purpose:
B-cell chronic lymphocytic leukemia (B-CLL) is an incurable disease that rapidly develops drug resistance. Therefore there is a need for identifying new agents that will improve the therapeutic outcome. Korbazol is a natural product known to exert cytotoxic effect on the in vitro survival of leukemic cells. The aim of this study was to investigate the mechanism of korbazol-induced apoptosis in B-CLL leukemic cells.
Methods:
peripheral blood mononuclear cells from 10 B-CLL patients were used for assessing the effect of caspase inhibitors and chelator of intracellular Ca(2)+.
Results:
cell death rate induced by the tested compound was decreased with the caspase-3 inhibitor Ac-DEVD-CHO, and the inhibitors of caspase-2 (Z-VDVAD-FMK) and -4 (ZYVAD- FMK), but not with the caspase-9 inhibitor z-LEHD-FMK and caspase-8 inhibitor z-IETD-FMK. No significant release of cytochrome C (cyt C) from mitochondria to the cytosol of B-CLL cells treated with korbazol was observed. Moreover, chelating of intracellular Ca(2)+ with BAPTA-AM almost completely abolished the cytotoxic effect of korbazol.
Conclusion:
engagement of caspases-2 and -4 and mobilization of intracellular Ca(2)+ indicate involvement of endoplasmic reticulum (ER) stress in apoptosis induced by korbazol.
Insights
Korbazol induces cell death in B-cell chronic lymphocytic leukemia (B-CLL) by activating caspases-2 and -4 and mobilizing calcium, suggesting endoplasmic reticulum stress is involved in this natural product
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- B-cell chronic lymphocytic leukemia (B-CLL) is an incurable hematologic malignancy.
- Drug resistance is a significant challenge in B-CLL treatment.
- Natural products offer potential therapeutic avenues for B-CLL.
Purpose of the Study:
- To elucidate the mechanism of apoptosis induced by the natural product Korbazol in B-CLL cells.
- To identify key molecular players involved in Korbazol-mediated cell death.
Main Methods:
- Peripheral blood mononuclear cells from B-CLL patients were treated with Korbazol.
- Caspase inhibitors (caspase-2, -3, -4, -8, -9) and a calcium chelator (BAPTA-AM) were used.
- Cytochrome C release was assessed to evaluate mitochondrial pathway involvement.
Main Results:
- Korbazol-induced cell death was reduced by inhibitors of caspase-2 and -4, but not caspase-8 or -9.
- No significant cytochrome C release was observed, indicating the mitochondrial pathway was not primarily involved.
- Intracellular calcium chelation with BAPTA-AM nearly abolished the cytotoxic effect of Korbazol.
Conclusions:
- Korbazol-induced apoptosis in B-CLL cells involves the activation of caspases-2 and -4.
- Mobilization of intracellular calcium is crucial for Korbazol's cytotoxic effect.
- These findings suggest that endoplasmic reticulum (ER) stress plays a role in Korbazol-mediated apoptosis.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Caspases
The Extrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
Apoptosis
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...

